6.34
price down icon10.07%   -0.71
pre-market  Vorhandelsmarkt:  6.31   -0.03   -0.47%
loading

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
2.15%
-18.05
-18.45 -28.67 -25.39 -35.88
Income/Loss From Continuing Operations Before Tax
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Income/Loss From Continuing Operations After Tax
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Net Income/Loss
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
123.56K%
56.30
0.0455 54.79 54.68 54.62
Diluted Average Shares
123.56K%
56.30
0.0455 54.79 54.68 54.62
Basic Earnings Per Share
0.00%
-0.30
-0.30 -0.49 -0.44 -0.63
Diluted Earnings Per Share
0.00%
-0.30
-0.30 -0.49 -0.44 -0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Kapitalisierung:     |  Volumen (24h):